Antidepressants and benzodiazepines for major depression
This evidence summary presents the best available evidence regarding the efficacy and safety of a combination of antidepressants and benzodiazepines for adults with major...
ICYMI: the latest in pharmacy
If you need to catch up on all the happenings in pharmacy post-break, Australian Pharmacist has you covered.
How to manage neuropathic pain
Neuropathic pain is defined as ‘pain caused by a lesion or disease of the somatosensory nervous system’.1
It is associated with impaired quality of...
Long COVID: managing the after-effects
Some people who are infected with COVID-19 do not recover quickly. They live with the aftermath – long COVID – a multi-system condition that we must start learning how to manage, including pharmacists.
Q&A: CPD planning
PSA has developed a CPD planning tool available free to members, that intuitively helps pharmacists through each of the required steps.
The science of safety
All about PSA Lifetime Fellow Dr John McEwen’s evolution from pharmacy apprentice to international authority on pharmacovigilance.













